한빛사논문 | BRIC

김상윤 님의 논문 목록

울산대학교 의과대학, 서울아산병원

CV File 304 kb

Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide-drug conjugate therapy in metastatic triple-negative breast cancer
- Biomaterials, Available online 2 September 2022 | https://doi.org/10.1016/j.biomaterials.2022.121783
- 2022-09
- 생명과학
- 한빛사논문
Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG
- J. Control. Release, Volume 346, June 2022, Pages 158-168 | https://doi.org/10.1016/j.jconrel.2022.04.012
- 2022-06
- 의약학
- 한빛사논문
Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer
- J. Control. Release, Volume 344, April 2022, Pages 26-38 | https://doi.org/10.1016/j.jconrel.2022.02.026
- 2022-04
- 의약학
- 한빛사논문
Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer
- Biomaterials, Volume 192, February 2019, Pages 109-117 | https://doi.org/10.1016/j.biomaterials.2018.11.001
- 2020-02
- 생명과학
- 한빛사논문
Self‐Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase‐Cleavable Linker
- Adv. Sci., Volume 5, Issue 7, July 2018 | https://doi.org/10.1002/advs.201800368
- 2018-07
- 생명과학
- 한빛사논문
Induced Phenotype Targeted Therapy: Radiation-Induced Apoptosis-Targeted Chemotherapy
- JNCI-J. Natl. Cancer Inst., February 2015, 107 (2): dju403 | doi: 10.1093/jnci/dju403
- 2015-02
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기